| Serial Number | 90845441 |
| Word Mark | TAVANTA |
| Filing Date | Friday, July 23, 2021 |
| Status | 731 - SECOND EXTENSION - GRANTED |
| Status Date | Thursday, May 2, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 7, 2023 |
| Goods and Services | Housemark for a full line of prescription pharmaceuticals for the treatment of cancer, anal fissures, cystic fibrosis; pharmaceuticals for treatment of cancer, and cystic fibrosis; pharmaceuticals exhibiting efficient drug release for the treatment of cancer, cystic fibrosis, and anal fissures |
| Goods and Services | Providing information about medical and scientific research; Providing information about medical and scientific research via a website |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, September 23, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, September 23, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Tavanta Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Radnor, PA 19087 |
| Party Name | Tavanta Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Radnor, PA 19087 |
| Event Date | Event Description |
| Tuesday, July 27, 2021 | NEW APPLICATION ENTERED |
| Thursday, September 23, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, April 18, 2022 | ASSIGNED TO EXAMINER |
| Monday, April 18, 2022 | NON-FINAL ACTION WRITTEN |
| Monday, April 18, 2022 | NON-FINAL ACTION E-MAILED |
| Monday, April 18, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, October 18, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, October 18, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, October 19, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, October 27, 2022 | SUSPENSION LETTER WRITTEN |
| Thursday, October 27, 2022 | LETTER OF SUSPENSION E-MAILED |
| Thursday, October 27, 2022 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Tuesday, November 29, 2022 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Monday, January 30, 2023 | ASSIGNED TO LIE |
| Monday, January 30, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, January 30, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, January 30, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, February 15, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, March 7, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, March 7, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 2, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, November 2, 2023 | SOU TEAS EXTENSION RECEIVED |
| Thursday, November 2, 2023 | SOU EXTENSION 1 FILED |
| Thursday, November 2, 2023 | SOU EXTENSION 1 GRANTED |
| Saturday, November 4, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, May 2, 2024 | SOU TEAS EXTENSION RECEIVED |
| Thursday, May 2, 2024 | SOU EXTENSION 2 FILED |
| Thursday, May 2, 2024 | SOU EXTENSION 2 GRANTED |
| Friday, May 3, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |